Search Within

Virginia Klimek

Formats
  1. Meeting Abstract (78)
  2. Journal Article (64)
  3. Editorial (2)
  4. Research Letter (2)
  5. Book Section (1)
Groups
  1. Adult Leukemia (147)
  2. Center for Hematologic Malignancies (147)
  3. Department of Medicine (147)
  4. Hematologic Malignancies, Division of (147)
  5. GSK Faculty (44)
  6. Epidemiology and Biostatistics (36)

More Groups

People
  1. Stephen Nimer (30)
  2. Sean Devlin (26)
  3. Martin Tallman (22)
  4. Ross Levine (21)
  5. Stephen Chung (18)
  6. Elli Papaemmanuil (14)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (8)
  6. 2019 (14)

More Years

Publications
  1. Blood (54)
  2. Leukemia Research (10)
  3. Journal of Clinical Oncology (9)
  4. Haematologica (8)
  5. Bone Marrow Transplantation (4)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (54)
  2. Nature Publishing Group (17)
  3. American Society of Clinical Oncology (10)
  4. Elsevier Ltd (10)
  5. Ferrata Storti Foundation (8)
  6. American Association for Cancer Research (6)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD99 identifies disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S. S.; Pang, W. W.; In, G. K.; Jan, M.; Klimek, V. M.; Melnick, A.; Weissman, I. L.; Majeti, R.; Park, C. Y.
    Blood (2012)

    Fulltext@MSK | Save
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Tees, M. T.; Devlin, S. M.; Stein, K.; Romero, A.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Smith, L.; Soff, G.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Arsenic trioxide followed by autologous stem cell transplant for patients with relapsed APL
    Meeting Abstract

    Shepard, D. D.; Kohrt, H. E.; Rosenblat, T. L.; Jurcic, J. G.; Park, J. H.; Goldman, A.; Dalal, J. S.; Maslak, P. G.; Jakubowski, A. A.; Klimek, V.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Mutational analysis of therapy-related MDS/AML
    Meeting Abstract

    Shih, A. H.; Chung, S. S.; Dolezal, E. K.; Zhang, S. J.; Abdel-Wahab, O.; Park, C. Y.; Nimer, S. D.; Levine, R. L.; Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • It dices, it splices!
    Journal Article

    Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Hypomethylating agents in acute lymphoblastic leukemia: Untapped potential?
    Journal Article

    Klimek, V. M.; Tallman, M. S.
    Leukemia and Lymphoma (2011)

    Fulltext@MSK | Save
  • Clinical activity of DNA methyltransferase inhibitors in therapy-related myelodysplastic syndromes: A retrospective study
    Meeting Abstract

    Tees, M. T.; Dolezal, E. K.; Nimer, S. D.; Klimek, V. M.
    Blood (2010)

    Fulltext@MSK | Save
  • Phase IIB trial of oral midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3
    Journal Article

    Fischer, T.; Stone, R. M.; DeAngelo, D. J.; Galinsky, I.; Estey, E.; Lanza, C.; Fox, E.; Ehninger, G.; Feldman, E. J.; Schiller, G. J.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save